Treatment outcome | Treatment group, No. (%) | |
---|---|---|
ASAQ (n = 156) | AL (n = 145) | |
No treatment outcome | 25 (16.0) | 20 (13.8) |
Lost to follow-up | 18 | 13 |
Other protocol deviations | 7 | 7 |
Adequate clinical and parasitological response | 118 (75.6) | 106 (73.1) |
Recurrent parasitaemia (including LCF and LPF) | 13 (7.4) | 19 (13.1) |
Recrudescence | 2 | 1 |
New infection | 9 | 17 |
Recurrent malaria due to non-falciparum species | 1 | 1 |
Genotyping not performed | 1 | 0 |